Dementia: Coronavirus

(asked on 14th May 2021) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will commit to (a) undertaking and (b) publishing a review of the prescription of anti-psychotic drugs to people with dementia during the covid-19 outbreak.


Answered by
Helen Whately Portrait
Helen Whately
Minister of State (Department of Health and Social Care)
This question was answered on 24th May 2021

The Department has no plans to conduct a review.

NHS England and NHS Improvement continue to monitor the monthly data published by NHS Digital on the prescribing of anti-psychotic medication for people diagnosed with dementia and continue to have regular conversations with regional clinical network leads and local services to understand the patterns in prescribing and potential reasons for those trends.

In addition, Public Health England has recently published factsheets which will help to provide context around prescribing activity and support initiation of conversations at a local level to facilitate an understanding of the patterns in prescribing. These factsheets are available at the following link:

https://fingertips.phe.org.uk/profile-group/mental-health/profile/dementia/data#page/

Reticulating Splines